Concepedia

Jae‐Lyun Lee

JL

Statistics

Publications

268

Citations

24.7K

H-Index

66

Active since

2002

Affiliations

University of Ulsan(Current)

Asan Medical Center

Ulsan College

Dana-Farber Cancer Institute

Samsung Medical Center

Jae‐Lyun Lee is an author at University of Ulsan specializing in medicine, oncology, and renal cell carcinoma.

ORCID

Publications per year

2002–2025

268

Publications

268

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

Joaquim Bellmunt, Ronald de Wit, David J. Vaughn et al. · New England Journal of Medicine · 2017 · 3.4K citations · Full text

, , +17

Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma

Toni K. Choueiri, Bernard Escudier, Thomas Powles et al. · New England Journal of Medicine · 2015 · 1.2K citations · Full text

, , +17

Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma

Thomas Powles, Jonathan E. Rosenberg, Guru Sonpavde et al. · New England Journal of Medicine · 2021 · 1.2K citations · Full text

, , +14

Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial

Brian I. Rini, Thomas Powles, Michael B. Atkins et al. · The Lancet · 2019 · 1K citations

, , +13

Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial

Toni K. Choueiri, Bernard Escudier, Thomas Powles et al. · The Lancet Oncology · 2016 · 939 citations · Full text

, , +12

1–5 of 268